Targeted Delivery of VEGF after a Myocardial Infarction Reduces Collagen Deposition and Improves Cardiac Function

Cardiovascular Engineering and Technology

Volumn 3, Issue 2, 2012, Pages 237-247

  Rosano, Jenna M ^a   Cheheltani, Rabee ^a   Wang, Bin ^a   Vora, Hardik ^b   Kiani, Mohammad F ^a,b   Crabbe, Deborah L ^a,b  

^a Temple University   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac remodeling; Diastolic function; Pro angiogenic compounds

Indexed keywords

CARDIAC FUNCTIONS; CARDIAC REMODELING; COLLAGEN DEPOSITION; DIASTOLIC FUNCTION; EJECTION FRACTION; EVOLUTIONARY CHANGES; FILLING PRESSURES; IMMUNOLIPOSOMES; INFARCT SIZE; LINEAR COMBINATIONS; LV FUNCTION; LV MASS; MULTI-REGRESSION ANALYSIS; MYOCARDIAL INFARCTION; PRO-ANGIOGENIC COMPOUNDS; SCAR FORMATION; SCAR TISSUES; TARGETED DELIVERY; TARGETED DRUG DELIVERY; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR PERFUSION;

DEPOSITION; DRUG DELIVERY; HEART; REGRESSION ANALYSIS; TISSUE;

COLLAGEN;

COLLAGEN; IMMUNOLIPOSOME; PADGEM PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN 165; VASCULOTROPIN 165A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; ENCAPSULATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR ENDDIASTOLIC DIAMETER; LEFT VENTRICULAR ENDSYSTOLIC DIAMETER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84861900727     PISSN: 1869408X     EISSN: 18694098     Source Type: Journal    
DOI: 10.1007/s13239-012-0089-3     Document Type: Article

References (26)

1. Carrabba, N., G. Parodi, R. Valenti, A. Migliorini, and D. Antoniucci. Comparison of effects of primary coronary angioplasty on left ventricular remodeling and heart failure in patients = 70 years with acute myocardial infarction. Am. J. Cardiol. 2009. doi: 10. 1016/j. amjcard. 2009. 05. 035.
2. Cohn, J. N., R. Ferrari, and N. Sharpe, on behalf of an Int Forum Cardiac Remodeling. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J. Am. Coll. Cardiol. 35: 569-582, 2000. doi: 10. 1016/S0735-1097(99)00630-0.
3. Ertl, G., and S. Frantz. Healing after myocardial infraction. Cardiovasc. Res. 2005. doi: 10. 1016/j. cardiores. 2005. 01. 011.
4. Feigenbaum, H., W. F. Armstrong, and T. Ryan. Evaluation of systolic and diastolic function of the left ventricle. In: Feigenbaum's Echocardiography, 2004.
5. Francis, G. S., and W. H. W. Tang. Natural history of cardiac remodeling. In: Cardiac Remodeling: Mechanism and Treatment, edited by B. Greenberg, 2006.
6. Freedman, S. B., and J. M. Isner. Therapeutic angiogenesis for ischemic cardiovascular disease. J. Mol. Cell. Cardiol. 2001. doi: 10. 1006/jmcc. 2000. 1329.
7. Ito, H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med. 2006. doi: 10. 1038/ncpcardio0632.
8. Ito, H., T. Tomooka, N. Sakai, H. Yu, Y. Higashino, K. Fujii, T. Masuyama, A. Kitabatake, and T. Minamino. Lack of myocardial perfusion immediately after successful thrombolysis-a predictor of poor recovery of left-ventricular function in anterior myocardial-infarction. Circulation 85(5): 1699-1705, 1992.
9. Jain, R. K., and L. L. Munn. Leaky vessels? Call Angll!. Nat. Med. 6: 131-132, 2000.
10. Lloyd-Jones, D. Heart disease and stroke statistics-2010 update: a report from the American Heart Association (vol 121, pg e46, 2010). Circulation 2010. doi: 10. 1161/CIR. 0b013e3181d7cf32.
11. Markel, T. A., Y. Wang, J. L. Herrmann, P. R. Crisostomo, M. Wang, N. M. Novotny, C. M. Herring, J. Tan, T. Lahm, and D. R. Meldrum. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am. J. Physiol.-Heart Circ. Physiol. 2008. doi: 10. 1152/ajpheart. 00565. 2008.
12. Matsumoto, R., T. Omura, M. Yoshiyama, T. Hayashi, S. Inamoto, K. R. Koh, K. Ohta, Y. Izumi, Y. Nakamura, K. Akioka, Y. Kitaura, K. Takeuchi, and J. Yoshikawa. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscl. Throm. Vasc. Biol. 2005. doi: 10. 1161/01. ATV. 0000165696. 25680. ce.
13. Miura, T., and T. Miki. Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy. Basic Res. Cardiol. 103: 501-513, 2008. doi: 10. 1007/s00395-008-0743-y.
14. Muller, R., and P. Buttner. A critical discussion of intraclass correlation-coefficients. Stat. Med. 13: 2465-2476, 1994.
15. Pfeffer, J. M., T. A. Fischer, and M. A. Pfeffer. Angiotensin-converting enzyme-inhibition and ventricular and remodeling after myocardial-infarction. Annu. Rev. Physiol. 57: 805-826, 1995. doi: 10. 1146/annurev. ph. 57. 030195. 004105.
16. Prunier, F., R. Gaertner, L. Louedec, J. B. Michel, J. J. Mercadier, and B. Escoubet. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am. J. Physiol.-Heart Circ. Physiol. 283: H346-H352, 2002. doi: 10. 1152/ajpheart. 01050. 2001.
17. Quinones, M. A., A. D. Waggoner, L. A. Reduto, J. G. Nelson, J. B. Young, W. L. Winters, L. G. Ribeiro, and R. R. Miller. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981.
18. Ross, A. M. The effects of tissue-plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular-function, and survival after acute myocardial-infarction (Vol 329, Pg 1615, 1993). N. Engl. J. Med. 1994.
19. Rudge, J. S., J. Holash, D. Hylton, M. Russell, S. Jiang, R. Leidich, N. Papadopoulos, E. A. Pyles, A. I. Torri, S. J. Wiegand, G. Thurston, N. Stahl, and G. D. Yancopoulos. VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade. Proc. Natl. Acad. Sci. USA 104: 18363-18370, 2007. doi: 10. 1073/pnas. 0708865104.
20. Scott, R. C., J. M. Rosano, Z. Ivanov, B. Wang, P. L. G. Chong, A. C. Issekutz, D. L. Crabbe, and M. F. Kiani. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J. 23: 3361-3367, 2009. doi: 10. 1096/fj. 08-127373.
21. Scott, R. C., B. Wang, R. Nallamothu, C. B. Pattillo, G. Perez-Liz, A. Issekutz, L. Del Valle, G. C. Wood, and M. F. Kiani. Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction. Biotechnol. Bioeng. 96: 795-802, 2007. doi: 10. 1002/bit. 21233.
22. Scott, R. C., D. Crabbe, B. Krynska, R. Ansari, and M. F. Kiani. Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue. Expert Opin. Drug Deliv. 5: 459-470, 2008. doi: 10. 1517/17425247. 5. 4. 459.
23. Scott, R. C. Targeting immunoliposomes containing pro-angiogenic compounds to the infarcted rat heart. 2008.
24. Walter, U. M., L. M. Ayer, B. A. Wolitzky, D. D. Wagner, R. O. Hynes, A. M. Manning, and A. C. Issekutz. Characterization of a novel adhesion function blocking monoclonal antibody to rat/mouse P-selectin generated in the P-selectin-deficient mouse. Hybridoma. 16: 249-257, 1997.
25. Whittaker, P., R. A. Kloner, D. R. Boughner, and J. G. Pickering. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly-polarized light. Basic Res. Cardiol. 89: 397-410, 1994.
26. Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash. Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000. doi: 10. 1038/35025215.